# FDA Inspection 1259338 - Ursapharm Arzneimittel GmbH - October 31, 2024

Source: https://www.keypedia.com/records/fda_inspections/ursapharm-arzneimittel-gmbh/08ba2bba-c6f8-42ab-b92e-d8aa4b2558dc
Source feed: FDA_Inspections

> FDA Inspection 1259338 for Ursapharm Arzneimittel GmbH on October 31, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1259338
- Company Name: Ursapharm Arzneimittel GmbH
- Inspection Date: 2024-10-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1259338 - 2024-10-31](https://www.keypedia.com/records/fda_inspections/ursapharm-arzneimittel-gmbh/34fc7f54-1b2f-47a3-bd98-822e944f02df)
- [FDA Inspection 945426 - 2015-09-25](https://www.keypedia.com/records/fda_inspections/ursapharm-arzneimittel-gmbh/163294c1-dabb-4119-a990-ae062ef4acf8)
- [FDA Inspection 854124 - 2013-09-13](https://www.keypedia.com/records/fda_inspections/ursapharm-arzneimittel-gmbh/81afa5c0-97a3-47d8-bbb4-1f1cbbc44064)

Company: https://www.keypedia.com/companies/ursapharm-arzneimittel-gmbh/2ce306b7-6cf8-4c56-aecc-03f34fc7cb3e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c